Magnetic resonance imaging (MRI) of the liver has traditionally been focused on the detection and characterization of focal liver lesions. However, diffuse liver diseases such as hepatic steatosis and cirrhosis are prevalent and often precede focal lesions like hepatocellular carcinoma. Therefore, new quantitative MRI biomarkers are needed for accurate characterization and quantification of diffuse liver disease. A multiparametric combination of quantitative MRI and elastography can noninvasively assess and grade the degree of liver steatosis, inflammation, congestion, and fibrosis. This lecture will highlight the strengths and limitations of multiparametric MRI for noninvasive imaging characterization of diffuse liver disease. Clinical applications are discussed, particularly in non-alcoholic fatty liver disease (NAFLD) with a high global pooled prevalence estimated at 25%. In addition, future perspectives for multiparametric MRI will be highlighted.

The lecture will be currently held as a Zoom Meeting,please connect using:

https://unibe-ch.zoom.us/j/61954796127?pwd=b25nSWVIVi9PWlV4Vlp3NXpMdjRQdz09

and do spread the word to anybody potentially interested.

For further info please contact: bernd.jung@insel.ch